Models of vertical cytomegalovirus (CMV) transmission and pathogenesis

Seminars in Immunopathology

Volumn 36, Issue 6, 2014, Pages 615-625

  Weisblum, Yiska ^a   Panet, Amos ^a   Haimov Kochman, Ronit ^a   Wolf, Dana G ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL FUNCTIONS; CHORION VILLUS; CONGENITAL INFECTION; CYTOMEGALOVIRUS INFECTION; DECIDUA; EX VIVO STUDY; EXPLANT; GUINEA PIG MODEL; HUMAN; HUMAN CYTOMEGALOVIRUS; IN VIVO STUDY; MOLECULAR BIOLOGY; MOTHER FETUS RELATIONSHIP; NONHUMAN; ORGAN CULTURE; PLACENTA; PRIORITY JOURNAL; REVIEW; VERTICAL TRANSMISSION; VIRUS PATHOGENESIS; ANIMAL; CYTOMEGALOVIRUS; DISEASE MODEL; FEMALE; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; PHYSIOLOGY; PREGNANCY; TRANSMISSION; VIROLOGY;

ANIMALS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; IMMUNE TOLERANCE; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; PLACENTA; PREGNANCY;

EID: 84922087697     PISSN: 18632297     EISSN: 18632300     Source Type: Journal    
DOI: 10.1007/s00281-014-0449-1     Document Type: Review

References (148)

1. Dollard SC, Grosse SD, Ross DS (2007) New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection. Rev Med Virol 17:355–363
2. Kenneson A, Cannon MJ (2007) Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection. Rev Med Virol 17:253–276
3. Kern ER (2006) Pivotal role of animal models in the development of new therapies for cytomegalovirus infections. Antiviral Res 71:164–171
4. Manicklal S, Emery VC, Lazzarotto T, Boppana SB, Gupta RK (2013) The “silent” global burden of congenital cytomegalovirus. Clin Microbiol Rev 26:86–102
5. Nelson CT, Demmler GJ (1997) Cytomegalovirus infection in the pregnant mother, fetus, and newborn infant. Clin Perinatol 24:151–160
6. Stagno S, Cloud G, Pass RF, Britt WJ, Alford CA (1984) Factors associated with primary cytomegalovirus infection during pregnancy. J Med Virol 13:347–353
7. Cannon MJ, Davis KF (2005) Washing our hands of the congenital cytomegalovirus disease epidemic. BMC Public Health 5:70
8. Boppana SB, Fowler KB, Pass RF, Rivera LB, Bradford RD, Lakeman FD et al (2005) Congenital cytomegalovirus infection: association between virus burden in infancy and hearing loss. J Pediatr 146:817–823
9. Fowler KB, Boppana SB (2006) Congenital cytomegalovirus (CMV) infection and hearing deficit. J Clin Virol 35:226–231
10. Longo S, Borghesi A, Tzialla C, Stronati M (2014) IUGR and infections. Early Hum Dev 90(Suppl 1):S42–S44
11. Pereira L, Petitt M, Fong A, Tsuge M, Tabata T, Fang-Hoover J et al (2014) Intrauterine growth restriction caused by underlying congenital cytomegalovirus infection. J Infect Dis 209:1573–1584
12. Daiminger A, Bader U, Enders G (2005) Pre- and periconceptional primary cytomegalovirus infection: risk of vertical transmission and congenital disease. BJOG 112:166–172
13. Enders G, Daiminger A, Bader U, Exler S, Enders M (2011) Intrauterine transmission and clinical outcome of 248 pregnancies with primary cytomegalovirus infection in relation to gestational age. J Clin Virol 52:244–246
14. Liesnard C, Donner C, Brancart F, Gosselin F, Delforge ML, Rodesch F (2000) Prenatal diagnosis of congenital cytomegalovirus infection: prospective study of 237 pregnancies at risk. Obstet Gynecol 95:881–888
15. Pass RF, Fowler KB, Boppana SB, Britt WJ, Stagno S (2006) Congenital cytomegalovirus infection following first trimester maternal infection: symptoms at birth and outcome. J Clin Virol 35:216–220
16. Stagno S, Pass RF, Cloud G, Britt WJ, Henderson RE, Walton PD et al (1986) Primary cytomegalovirus infection in pregnancy. Incidence, transmission to fetus, and clinical outcome. JAMA 256:1904–1908
17. Arvin AM, Fast P, Myers M, Plotkin S, Rabinovich R (2004) National Vaccine Advisory C. Vaccine development to prevent cytomegalovirus disease: report from the National Vaccine Advisory Committee. Clin Infect Dis 39:233–239
18. Mocarski ES, Shenk T, Pass RF (2007) Cytomegaloviruses. In: Knipe DM, Howly PM, Griffin DE, Lamb RA, Martin MA (eds) Fields virology, 5th edn. Lippincott Williams and Wilkins, Philadelphia
19. Enders AC (1965) A comparative study of the fine structure of the trophoblast in several hemochorial placentas. Am J Anat 116:29–67
20. Maltepe E, Bakardjiev AI, Fisher SJ (2010) The placenta: transcriptional, epigenetic, and physiological integration during development. J Clin Invest 120:1016–1025
21. McGregor A, Choi KY (2011) Cytomegalovirus antivirals and development of improved animal models. Expert Opin Drug Metab Toxicol 7:1245–1265
22. Schlub TE, Sun JC, Walton SM, Robbins SH, Pinto AK, Munks MW et al (2011) Comparing the kinetics of NK cells, CD4, and CD8 T cells in murine cytomegalovirus infection. J Immunol 187:1385–1392
23. Mutnal MB, Cheeran MC, Hu S, Lokensgard JR (2011) Murine cytomegalovirus infection of neural stem cells alters neurogenesis in the developing brain. PLoS One 6:e16211
24. Sun JC, Beilke JN, Lanier LL (2009) Adaptive immune features of natural killer cells. Nature 457:557–561
25. Slavuljica I, Kvestak D, Csaba Huszthy P, Kosmac K, Britt WJ, Jonjic S (2014) Immunobiology of congenital cytomegalovirus infection of the central nervous system-the murine cytomegalovirus model. Cell Mol Immunol. doi:10.1038/cmi.2014.51
26. Cekinovic D, Golemac M, Pugel EP, Tomac J, Cicin-Sain L, Slavuljica I et al (2008) Passive immunization reduces murine cytomegalovirus-induced brain pathology in newborn mice. J Virol 82:12172–12180
27. Kumar ML, Nankervis GA (1978) Experimental congenital infection with cytomegalovirus: a guinea pig model. J Infect Dis 138:650–654
28. Schleiss MR (2008) Comparison of vaccine strategies against congenital CMV infection in the guinea pig model. J Clin Virol 41:224–230
29. Schleiss MR, McVoy MA (2010) Guinea pig cytomegalovirus (GPCMV): a model for the study of the prevention and treatment of maternal-fetal transmission. Futur Virol 5:207–217
30. Woolf NK, Koehrn FJ, Harris JP, Richman DD (1989) Congenital cytomegalovirus labyrinthitis and sensorineural hearing loss in guinea pigs. J Infect Dis 160:929–937
31. Weisblum Y, Panet A, Zakay-Rones Z, Haimov-Kochman R, Goldman-Wohl D, Ariel I et al (2011) Modeling of human cytomegalovirus maternal-fetal transmission in a novel decidual organ culture. J Virol 85:13204–13213
32. Cross JC, Werb Z, Fisher SJ (1994) Implantation and the placenta: key pieces of the development puzzle. Science 266:1508–1518
33. Hamilton WJ, Boyd JD (1960) Development of the human placenta in the first three months of gestation. J Anat 94:297–328
34. Rossant J, Cross JC (2001) Placental development: lessons from mouse mutants. Nat Rev Genet 2:538–548
35. Adler SP, Nigro G, Pereira L (2007) Recent advances in the prevention and treatment of congenital cytomegalovirus infections. Semin Perinatol 31:10–18
36. Knofler M (2010) Critical growth factors and signalling pathways controlling human trophoblast invasion. Int J Dev Biol 54:269–280
37. Pereira L, Maidji E, McDonagh S, Tabata T (2005) Insights into viral transmission at the uterine-placental interface. Trends Microbiol 13:164–174
38. Red-Horse K, Zhou Y, Genbacev O, Prakobphol A, Foulk R, McMaster M et al (2004) Trophoblast differentiation during embryo implantation and formation of the maternal-fetal interface. J Clin Invest 114:744–754
39. Lyall F, Robson SC, Bulmer JN (2013) Spiral artery remodeling and trophoblast invasion in preeclampsia and fetal growth restriction: relationship to clinical outcome. Hypertension 62:1046–1054
40. Zhou Y, Gormley MJ, Hunkapiller NM, Kapidzic M, Stolyarov Y, Feng V et al (2013) Reversal of gene dysregulation in cultured cytotrophoblasts reveals possible causes of preeclampsia. J Clin Invest 123:2862–2872
41. Burton GJ, Jauniaux E, Charnock-Jones DS (2010) The influence of the intrauterine environment on human placental development. Int J Dev Biol 54:303–312
42. Hustin J, Gillerot Y, Collette J, Franchimont P (1990) Placental alkaline phosphatase in developing normal and abnormal gonads and in germ-cell tumours. Virchows Arch A Pathol Anat Histopathol 417:67–72
43. Jauniaux E, Van Oppenraaij RH, Burton GJ (2010) Obstetric outcome after early placental complications. Curr Opin Obstet Gynecol 22:452–457
44. John R, Hemberger M (2012) A placenta for life. Reprod Biomed Online 25:5–11
45. Norwitz ER (2006) Defective implantation and placentation: laying the blueprint for pregnancy complications. Reprod Biomed Online 13:591–599
46. Pijnenborg R, Anthony J, Davey DA, Rees A, Tiltman A, Vercruysse L et al (1991) Placental bed spiral arteries in the hypertensive disorders of pregnancy. Br J Obstet Gynaecol 98:648–655
47. Pijnenborg R, Ball E, Bulmer JN, Hanssens M, Robson SC, Vercruysse L (2006) In vivo analysis of trophoblast cell invasion in the human. Methods Mol Med 122:11–44
48. Arck PC, Hecher K (2013) Fetomaternal immune cross-talk and its consequences for maternal and offspring’s health. Nat Med 19:548–556
49. Erlebacher A (2013) Immunology of the maternal-fetal interface. Annu Rev Immunol 31:387–411
50. Mor G, Cardenas I (2010) The immune system in pregnancy: a unique complexity. Am J Reprod Immunol 63:425–433
51. Zenclussen AC (2013) Adaptive immune responses during pregnancy. Am J Reprod Immunol 69:291–303
52. Mouillet JF, Ouyang Y, Bayer A, Coyne CB, Sadovsky Y (2014) The role of trophoblastic microRNAs in placental viral infection. Int J Dev Biol 58:281–289
53. Zeldovich VB, Bakardjiev AI (2012) Host defense and tolerance: unique challenges in the placenta. PLoS Pathog 8:e1002804
54. Bainbridge DR (2000) Evolution of mammalian pregnancy in the presence of the maternal immune system. Rev Reprod 5:67–74
55. Ishitani A, Sageshima N, Lee N, Dorofeeva N, Hatake K, Marquardt H et al (2003) Protein expression and peptide binding suggest unique and interacting functional roles for HLA-E, F, and G in maternal-placental immune recognition. J Immunol 171:1376–1384
56. Rapacz-Leonard A, Dabrowska M, Janowski T (2014) Major histocompatibility complex I mediates immunological tolerance of the trophoblast during pregnancy and may mediate rejection during parturition. Mediat Inflamm 2014:579279
57. Bulmer JN, Pace D, Ritson A (1988) Immunoregulatory cells in human decidua: morphology, immunohistochemistry and function. Reprod Nutr Dev 28:1599–1613
58. King A, Loke YW, Chaouat G (1997) NK cells and reproduction. Immunol Today 18:64–66
59. Mor G, Straszewski-Chavez SL, Abrahams VM (2006) Macrophage-trophoblast interactions. Methods Mol Med 122:149–163
60. Wicherek L, Basta P, Pitynski K, Marianowski P, Kijowski J, Wiatr J et al (2009) The characterization of the subpopulation of suppressive B7H4(+) macrophages and the subpopulation of CD25(+) CD4(+) and FOXP3(+) regulatory T-cells in decidua during the secretory cycle phase, Arias Stella reaction, and spontaneous abortion - a preliminary report. Am J Reprod Immunol 61:303–312
61. Manaster I, Mandelboim O (2010) The unique properties of uterine NK cells. Am J Reprod Immunol 63:434–444
62. Hunt JS (2006) Stranger in a strange land. Immunol Rev 213:36–47
63. Red-Horse K, Drake PM, Fisher SJ (2004) Human pregnancy: the role of chemokine networks at the fetal-maternal interface. Expert Rev Mol Med 6:1–14
64. Nancy P, Tagliani E, Tay CS, Asp P, Levy DE, Erlebacher A (2012) Chemokine gene silencing in decidual stromal cells limits T cell access to the maternal-fetal interface. Science 336:1317–1321
65. Redman CW, Sargent IL (2010) Immunology of pre-eclampsia. Am J Reprod Immunol 63:534–543
66. Hanna J, Goldman-Wohl D, Hamani Y, Avraham I, Greenfield C, Natanson-Yaron S et al (2006) Decidual NK cells regulate key developmental processes at the human fetal-maternal interface. Nat Med 12:1065–1074
67. Hanna J, Mandelboim O (2007) When killers become helpers. Trends Immunol 28:201–206
68. Kalkunte S, Chichester CO, Gotsch F, Sentman CL, Romero R, Sharma S (2008) Evolution of non-cytotoxic uterine natural killer cells. Am J Reprod Immunol 59:425–432
69. Moffett-King A (2002) Natural killer cells and pregnancy. Nat Rev Immunol 2:656–663
70. Hiby SE, Walker JJ, O’Shaughnessy KM, Redman CW, Carrington M, Trowsdale J et al (2004) Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success. J Exp Med 200:957–965
71. Mor G, Romero R, Aldo PB, Abrahams VM (2005) Is the trophoblast an immune regulator? The role of Toll-like receptors during pregnancy. Crit Rev Immunol 25:375–388
72. Barry PA, Lockridge KM, Salamat S, Tinling SP, Yue Y, Zhou SS et al (2006) Nonhuman primate models of intrauterine cytomegalovirus infection. ILAR J/Natl Res Counc Inst Lab Anim Res 47:49–64
73. Schleiss MR (2002) Animal models of congenital cytomegalovirus infection: an overview of progress in the characterization of guinea pig cytomegalovirus (GPCMV). J Clin Virol 25(Suppl 2):S37–S49
74. Schleiss MR (2006) Nonprimate models of congenital cytomegalovirus (CMV) infection: gaining insight into pathogenesis and prevention of disease in newborns. ILAR J/Natl Res Counc Inst Lab Anim Res 47:65–72
75. Wynn KK, Khanna R (2006) Models of CMV infection. Drug Discov Today: Dis Models 3:91–96
76. Forbes CA, Brown MG, Cho R, Shellam GR, Yokoyama WM, Scalzo AA (1997) The Cmv1 host resistance locus is closely linked to the Ly49 multigene family within the natural killer cell gene complex on mouse chromosome 6. Genomics 41:406–413
77. Rodriguez M, Sabastian P, Clark P, Brown MG (2004) Cmv1-independent antiviral role of NK cells revealed in murine cytomegalovirus-infected New Zealand White mice. J Immunol 173:6312–6318
78. Scalzo AA, Fitzgerald NA, Simmons A, La Vista AB, Shellam GR (1990) Cmv-1, a genetic locus that controls murine cytomegalovirus replication in the spleen. J Exp Med 171:1469–1483
79. Johnson KP (1969) Mouse cytomegalovirus: placental infection. J Infect Dis 120:445–450
80. Li RY, Tsutsui Y (2000) Growth retardation and microcephaly induced in mice by placental infection with murine cytomegalovirus. Teratology 62:79–85
81. Kawasaki H, Kosugi I, Arai Y, Tsutsui Y (2002) The amount of immature glial cells in organotypic brain slices determines the susceptibility to murine cytomegalovirus infection. Lab Invest 82:1347–1358
82. Cheeran MC, Lokensgard JR, Schleiss MR (2009) Neuropathogenesis of congenital cytomegalovirus infection: disease mechanisms and prospects for intervention. Clin Microbiol Rev 22:99–126, Table of Contents
83. Kosugi I, Shinmura Y, Kawasaki H, Arai Y, Li RY, Baba S et al (2000) Cytomegalovirus infection of the central nervous system stem cells from mouse embryo: a model for developmental brain disorders induced by cytomegalovirus. Lab Invest 80:1373–1383
84. Bantug GR, Cekinovic D, Bradford R, Koontz T, Jonjic S, Britt WJ (2008) CD8+ T lymphocytes control murine cytomegalovirus replication in the central nervous system of newborn animals. J Immunol 181:2111–2123
85. Schachtele SJ, Mutnal MB, Schleiss MR, Lokensgard JR (2011) Cytomegalovirus-induced sensorineural hearing loss with persistent cochlear inflammation in neonatal mice. J Neurovirol 17:201–211
86. Kosmac K, Bantug GR, Pugel EP, Cekinovic D, Jonjic S, Britt WJ (2013) Glucocorticoid treatment of MCMV infected newborn mice attenuates CNS inflammation and limits deficits in cerebellar development. PLoS Pathog 9:e1003200
87. Gabrielli L, Bonasoni MP, Lazzarotto T, Lega S, Santini D, Foschini MP et al (2009) Histological findings in foetuses congenitally infected by cytomegalovirus. J Clin Virol 46(Suppl 4):S16–S21
88. Griffith BP, McCormick SR, Fong CK, Lavallee JT, Lucia HL, Goff E (1985) The placenta as a site of cytomegalovirus infection in guinea pigs. J Virol 55:402–409
89. Bia FJ, Griffith BP, Fong CK, Hsiung GD (1983) Cytomegaloviral infections in the guinea pig: experimental models for human disease. Rev Infect Dis 5:177–195
90. Choi YC, Hsiung GD (1978) Cytomegalovirus infection in guinea pigs. II. Transplacental and horizontal transmission. J Infect Dis 138:197–202
91. Johnson KP, Connor WS (1979) Guinea pig cytomegalovirus: transplacental transmission. Brief report. Arch Virol 59:263–267
92. Griffith BP, Lucia HL, Hsiung GD (1982) Brain and visceral involvement during congenital cytomegalovirus infection of guinea pigs. Pediatr Res 16:455–459
93. Katano H, Sato Y, Tsutsui Y, Sata T, Maeda A, Nozawa N et al (2007) Pathogenesis of cytomegalovirus-associated labyrinthitis in a guinea pig model. Microbes Infect 9:183–191
94. Schraff SA, Schleiss MR, Brown DK, Meinzen-Derr J, Choi KY, Greinwald JH et al (2007) Macrophage inflammatory proteins in cytomegalovirus-related inner ear injury. Otolaryngol Head Neck Surg 137:612–618
95. Leviton MP, Lacayo JC, Choi KY, Hernandez-Alvarado N, Wey A, Schleiss MR (2013) An attenuated cytomegalovirus vaccine with a deletion of a viral chemokine gene is protective against congenital CMV transmission in a guinea pig model. Clin Dev Immunol 2013:906948
96. McDonagh S, Maidji E, Ma W, Chang HT, Fisher S, Pereira L (2004) Viral and bacterial pathogens at the maternal-fetal interface. J Infect Dis 190:826–834
97. Revello MG, Gerna G (2004) Pathogenesis and prenatal diagnosis of human cytomegalovirus infection. J Clin Virol 29:71–83
98. Trincado DE, Munro SC, Camaris C, Rawlinson WD (2005) Highly sensitive detection and localization of maternally acquired human cytomegalovirus in placental tissue by in situ polymerase chain reaction. J Infect Dis 192:650–657
99. Mostoufi-zadeh M, Driscoll SG, Biano SA, Kundsin RB (1984) Placental evidence of cytomegalovirus infection of the fetus and neonate. Arch Pathol Lab Med 108:403–406
100. Muhlemann K, Miller RK, Metlay L, Menegus MA (1992) Cytomegalovirus infection of the human placenta: an immunocytochemical study. Hum Pathol 23:1234–1237
101. Fisher S, Genbacev O, Maidji E, Pereira L (2000) Human cytomegalovirus infection of placental cytotrophoblasts in vitro and in utero: implications for transmission and pathogenesis. J Virol 74:6808–6820
102. Kumazaki K, Ozono K, Yahara T, Wada Y, Suehara N, Takeuchi M et al (2002) Detection of cytomegalovirus DNA in human placenta. J Med Virol 68:363–369
103. Sinzger C, Muntefering H, Loning T, Stoss H, Plachter B, Jahn G (1993) Cell types infected in human cytomegalovirus placentitis identified by immunohistochemical double staining. Virchows Archiv A Pathol Anat Histopathol 423:249–256
104. Adler SP, Nigro G (2009) Findings and conclusions from CMV hyperimmune globulin treatment trials. J Clin Virol 46(Suppl 4):S54–S57
105. Schleiss MR, Aronow BJ, Handwerger S (2007) Cytomegalovirus infection of human syncytiotrophoblast cells strongly interferes with expression of genes involved in placental differentiation and tissue integrity. Pediatr Res 61:565–571
106. Schleiss MR (2006) The role of the placenta in the pathogenesis of congenital cytomegalovirus infection: is the benefit of cytomegalovirus immune globulin for the newborn mediated through improved placental health and function? Clin Infect Dis 43:1001–1003
107. Gabrielli L, Bonasoni MP, Santini D, Piccirilli G, Chiereghin A, Petrisli E et al (2012) Congenital cytomegalovirus infection: patterns of fetal brain damage. Clin Microbiol Infect 18:E419–E427
108. Garcia AG, Fonseca EF, Marques RL, Lobato YY (1989) Placental morphology in cytomegalovirus infection. Placenta 10:1–18
109. Maidji E, Nigro G, Tabata T, McDonagh S, Nozawa N, Shiboski S et al (2010) Antibody treatment promotes compensation for human cytomegalovirus-induced pathogenesis and a hypoxia-like condition in placentas with congenital infection. Am J Pathol 177:1298–1310
110. Hamilton ST, Scott G, Naing Z, Iwasenko J, Hall B, Graf N et al (2012) Human cytomegalovirus-induces cytokine changes in the placenta with implications for adverse pregnancy outcomes. PLoS One 7:e52899
111. Pereira L, Maidji E, McDonagh S, Genbacev O, Fisher S (2003) Human Cytomegalovirus Transmission from the Uterus to the Placenta Correlates with the Presence of Pathogenic Bacteria and Maternal Immunity. J Virol 77:13301–13314
112. La Torre R, Nigro G, Mazzocco M, Best AM, Adler SP (2006) Placental enlargement in women with primary maternal cytomegalovirus infection is associated with fetal and neonatal disease. Clin Infect Dis 43:994–1000
113. Halwachs-Baumann G, Wilders-Truschnig M, Desoye G, Hahn T, Kiesel L, Klingel K et al (1998) Human trophoblast cells are permissive to the complete replicative cycle of human cytomegalovirus. J Virol 72:7598–7602
114. Hemmings DG, Kilani R, Nykiforuk C, Preiksaitis J, Guilbert LJ (1998) Permissive cytomegalovirus infection of primary villous term and first trimester trophoblasts. J Virol 72:4970–4979
115. Maidji E, Percivalle E, Gerna G, Fisher S, Pereira L (2002) Transmission of human cytomegalovirus from infected uterine microvascular endothelial cells to differentiating/invasive placental cytotrophoblasts. Virology 304:53–69
116. Halwachs-Baumann G, Weihrauch G, Gruber HJ, Desoye G, Sinzger C (2006) hCMV induced IL-6 release in trophoblast and trophoblast like cells. J Clin Virol 37:91–97
117. Hemmings DG, Guilbert LJ (2002) Polarized release of human cytomegalovirus from placental trophoblasts. J Virol 76:6710–6717
118. Gabrielli L, Losi L, Varani S, Lazzarotto T, Eusebi V, Landini MP (2001) Complete replication of human cytomegalovirus in explants of first trimester human placenta. J Med Virol 64:499–504
119. Maidji E, Genbacev O, Chang HT, Pereira L (2007) Developmental regulation of human cytomegalovirus receptors in cytotrophoblasts correlates with distinct replication sites in the placenta. J Virol 81:4701–4712
120. Maidji E, McDonagh S, Genbacev O, Tabata T, Pereira L (2006) Maternal antibodies enhance or prevent cytomegalovirus infection in the placenta by neonatal Fc receptor-mediated transcytosis. Am J Pathol 168:1210–1226
121. Yamamoto-Tabata T, McDonagh S, Chang HT, Fisher S, Pereira L (2004) Human cytomegalovirus interleukin-10 downregulates metalloproteinase activity and impairs endothelial cell migration and placental cytotrophoblast invasiveness in vitro. J Virol 78:2831–2840
122. LaMarca HL, Nelson AB, Scandurro AB, Whitley GS, Morris CA (2006) Human cytomegalovirus-induced inhibition of cytotrophoblast invasion in a first trimester extravillous cytotrophoblast cell line. Placenta 27:137–147
123. Tao L, Suhua C, Juanjuan C, Zongzhi Y, Juan X, Dandan Z (2011) In vitro study on human cytomegalovirus affecting early pregnancy villous EVT’s invasion function. Virol J 8:114
124. Warner JA, Zwezdaryk KJ, Day B, Sullivan DE, Pridjian G, Morris CA (2012) Human cytomegalovirus infection inhibits CXCL12- mediated migration and invasion of human extravillous cytotrophoblasts. Virol J 9:255
125. Pereira L, Petitt M, Tabata T (2013) Cytomegalovirus infection and antibody protection of the developing placenta. Clin Inf Dis 57(Suppl 4):S174–S177
126. Tabata T, Kawakatsu H, Maidji E, Sakai T, Sakai K, Fang-Hoover J et al (2008) Induction of an epithelial integrin alphavbeta6 in human cytomegalovirus-infected endothelial cells leads to activation of transforming growth factor-beta1 and increased collagen production. Am J Pathol 172:1127–1140
127. Tabata T, McDonagh S, Kawakatsu H, Pereira L (2007) Cytotrophoblasts infected with a pathogenic human cytomegalovirus strain dysregulate cell-matrix and cell-cell adhesion molecules: a quantitative analysis. Placenta 28:527–537
128. Tabata T, Petitt M, Fang-Hoover J, Rivera J, Nozawa N, Shiboski S et al (2012) Cytomegalovirus impairs cytotrophoblast-induced lymphangiogenesis and vascular remodeling in an in vivo human placentation model. Am J Pathol 181:1540–1559
129. Angelova M, Zwezdaryk K, Ferris M, Shan B, Morris CA, Sullivan DE (2012) Human cytomegalovirus infection dysregulates the canonical Wnt/beta-catenin signaling pathway. PLoS Pathog 8:e1002959
130. Rauwel B, Mariame B, Martin H, Nielsen R, Allart S, Pipy B et al (2010) Activation of peroxisome proliferator-activated receptor gamma by human cytomegalovirus for de novo replication impairs migration and invasiveness of cytotrophoblasts from early placentas. J Virol 84:2946–2954
131. Chan G, Guilbert LJ (2006) Ultraviolet-inactivated human cytomegalovirus induces placental syncytiotrophoblast apoptosis in a Toll-like receptor-2 and tumour necrosis factor-alpha dependent manner. J Pathol 210:111–120
132. Chaudhuri S, Lowen B, Chan G, Davey A, Riddell M, Guilbert LJ (2009) Human cytomegalovirus interacts with toll-like receptor 2 and CD14 on syncytiotrophoblasts to stimulate expression of TNFalpha mRNA and apoptosis. Placenta 30:994–1001
133. Chan G, Hemmings DG, Yurochko AD, Guilbert LJ (2002) Human cytomegalovirus-caused damage to placental trophoblasts mediated by immediate-early gene-induced tumor necrosis factor-alpha. Am J Pathol 161:1371–1381
134. Schust DJ, Tortorella D, Seebach J, Phan C, Ploegh HL (1998) Trophoblast class I major histocompatibility complex (MHC) products are resistant to rapid degradation imposed by the human cytomegalovirus (HCMV) gene products US2 and US11. J Exp Med 188:497–503
135. Siewiera J, El Costa H, Tabiasco J, Berrebi A, Cartron G, Le Bouteiller P et al (2013) Human cytomegalovirus infection elicits new decidual natural killer cell effector functions. PLoS Pathog 9:e1003257
136. Terauchi M, Koi H, Hayano C, Toyama-Sorimachi N, Karasuyama H, Yamanashi Y et al (2003) Placental extravillous cytotrophoblasts persistently express class I major histocompatibility complex molecules after human cytomegalovirus infection. J Virol 77:8187–8195
137. Jun Y, Kim E, Jin M, Sung HC, Han H, Geraghty DE et al (2000) Human cytomegalovirus gene products US3 and US6 down-regulate trophoblast class I MHC molecules. J Immunol 164:805–811
138. Park B, Spooner E, Houser BL, Strominger JL, Ploegh HL (2010) The HCMV membrane glycoprotein US10 selectively targets HLA-G for degradation. J Exp Med 207:2033–2041
139. Jarvis MA, Nelson JA (2007) Human cytomegalovirus tropism for endothelial cells: not all endothelial cells are created equal. J Virol 81:2095–2101
140. Sinzger C, Digel M, Jahn G (2008) Cytomegalovirus cell tropism. Curr Top Microbiol Immunol 325:63–83
141. Pereira L, Maidji E (2008) Cytomegalovirus infection in the human placenta: maternal immunity and developmentally regulated receptors on trophoblasts converge. Curr Top Microbiol Immunol 325:383–395
142. Compton T, Nepomuceno RR, Nowlin DM (1992) Human cytomegalovirus penetrates host cells by pH-independent fusion at the cell surface. Virology 191:387–395
143. Gerna G, Percivalle E, Lilleri D, Lozza L, Fornara C, Hahn G et al (2005) Dendritic-cell infection by human cytomegalovirus is restricted to strains carrying functional UL131-128 genes and mediates efficient viral antigen presentation to CD8+ T cells. J Gen Virol 86:275–284
144. Hahn G, Revello MG, Patrone M, Percivalle E, Campanini G, Sarasini A et al (2004) Human cytomegalovirus UL131-128 genes are indispensable for virus growth in endothelial cells and virus transfer to leukocytes. J Virol 78:10023–10033
145. Ryckman BJ, Jarvis MA, Drummond DD, Nelson JA, Johnson DC (2006) Human cytomegalovirus entry into epithelial and endothelial cells depends on genes UL128 to UL150 and occurs by endocytosis and low-pH fusion. J Virol 80:710–722
146. Wang D, Shenk T (2005) Human cytomegalovirus virion protein complex required for epithelial and endothelial cell tropism. Proc Natl Acad Sci U S A 102:18153–18158
147. Nigro G, Adler SP, La Torre R, Best AM, Congenital Cytomegalovirus Collaborating Group (2005) Passive immunization during pregnancy for congenital cytomegalovirus infection. N Engl J Med 353:1350–1362
148. Revello MG, Lazzarotto T, Guerra B, Spinillo A, Ferrazzi E, Kustermann A et al (2014) A randomized trial of hyperimmune globulin to prevent congenital cytomegalovirus. N Engl J Med 370:1316–1326